For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260414:nRSN2840Aa&default-theme=true
RNS Number : 2840A Porvair PLC 14 April 2026
14 April 2026
Porvair plc
("Porvair" or the "Group" or the "Company")
AGM Trading Update
Group trading remains in line with our full year expectations. Integration of
Drache acquisition remains on track.
Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory
and environmental technology group, will make the following trading statement
at its Annual General Meeting to be held at 11.00 am today:
Four-month trading summary for the period to 31 March 2026
The Group has performed in line with expectations in the first four months
of the year, delivering constant currency revenue growth of 5%. This
performance reflects the qualities of Porvair's diversified portfolio, as
market conditions remain varied across the Group's end markets.
Aerospace & Industrial
Aerospace order books remain strong, noting that the timing of delivery can be
affected by changes in customer scheduling. Robust nuclear demand in the
second half of 2025 has continued into the current year. Petrochemical sales,
which can be lumpy, are lower compared with a strong prior period, and
conditions in the European petrochemical market are expected to remain subdued
throughout 2026.
Laboratory
Within life sciences, consumables order patterns remain steady, while
environmental demand for instruments is in line with the prior year. New
product introductions across life sciences and environmental are progressing
as planned.
Metal Melt Quality
Aluminium and superalloys demand remains firm, whilst the auto, truck and
agriculture end-markets, which represent a smaller part of the Group, remain
subdued. There has been good progress with the new £5.5m aluminium cast house
manufacturing line in Hendersonville, US, which remains on track for
commissioning in the first half of 2026. The integration of Drache, acquired
on 12 January 2026, is progressing well after three months with the Group and
trading is consistent with the pre-acquisition investment case.
Outlook
The Board is closely monitoring the situation in the Middle East, in terms of
both macro uncertainty and rising input prices. The Group's manufacturing
footprint mainly serves local customers, and its decentralised management
structure provides flexibility, agility and resilience in navigating volatile
trading conditions, enabling key commercial decisions to be made closer to
customers and suppliers.
The Board's expectations of the Group's full year performance remain
unchanged, supported by a diversified customer base, strong recurring revenue
streams and disciplined operational management. An increased focus on
identifying M&A targets has surfaced some interesting prospects which are
currently being evaluated. The Board sees no change in the Group's long-term
strategic outlook or global growth drivers.
Capital Markets Event
Further to the full year results announcement, Porvair will host a Capital
Markets Event in London on Thursday, 15 October 2026. Further details will be
provided in due course.
Notice of results
The Group will announce its interim results for the six months ending 31 May
2026 on Monday 29 June 2026.
For further information, please contact:
Porvair plc +44 (0)1553 765 500
Hooman Caman Javvi, Chief Executive Officer
James Mills, Group Finance Director
Alma Strategic Communications +44 (0)20 3405 0205
Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty
LEI: 213800ECKHS8LAQO3C45
Notes to editors
Porvair is a group of specialist filtration, laboratory and environmental
technology companies. Our businesses design and manufacture bespoke consumable
filtration products that are used in a range of niche markets. It operates in
three divisions: Aerospace & Industrial; Laboratory; and Metal Melt
Quality.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGMEAFLDFASKEAA
Copyright 2019 Regulatory News Service, all rights reserved